Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Capillary driven microfluidic sequential flow device for point-of-need ELISA: COVID-19 serology testing

Analytical Methods(2023)10.1039/d3ay00225jSource: DataRank Database

Capillary driven microfluidic sequential flow device for point-of-need ELISA: COVID-19 serology testing is a research paper published in Analytical Methods (2023). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.84)OA: hybridTopics (40)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Ilhoon Jang ORCID,Jeremy Link ORCID,James S. Terry ORCID,Zachary Call,Yosita Panraksa

Live enrichment

PubMed:37099406 PMC:PMC10249653 OpenAlex:https://openalex.org/W4366321599

National Research Foundation of Korea

Grant: 2018R1A6A3A11043917

National Institutes of Health

Grant: 1R01AI132668

National Institutes of Health

Grant: HL152405

National Science Foundation

Grant: NSF STTR 2032222

NIBIB NIH HHS

Grant: R01 EB031510

NIAID NIH HHS

Grant: R01 AI132668

NIAID NIH HHS

Grant: T32 AI162691

National Institutes of Health

Grant: 5R01AI132668-03

Mechanism of Flavivirus RNA Capping

National Science Foundation

Grant: 2032222

STTR Phase I: Advanced Microfluidic Devices for Point-of-Care COVID-19 Serological Testing

National Institutes of Health

Grant: 1U01HL152405-01

Colorado AMC REACH Hub

FWCI

1.84

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://pubs.rsc.org/en/content/articlepdf/2023/ay/d3ay00225j

publisherhttps://pubs.rsc.org/en/content/articlepdf/2023/ay/d3ay00225j

publisherhttp://pubs.rsc.org/en/content/articlepdf/2023/AY/D3AY00225J

journalhttps://doi.org/10.1039/d3ay00225j

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37099406

Fields of Study

Biosensors and Analytical DetectionInnovative Microfluidic and Catalytic Techniques InnovationSARS-CoV-2 detection and testing0303 health sciences03 medical and health sciencesHumansSARS-CoV-2COVID-19MicrofluidicsReproducibility of ResultsEnzyme-Linked Immunosorbent AssayAntibodies, Viral

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralEnzyme-Linked Immunosorbent AssayHumansReproducibility of ResultsMicrofluidics

Keywords

SerologyCoronavirus disease 2019 (COVID-19)Point-of-care testingMicrofluidicsCapillary actionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakAntibodyMedicineNanotechnologyMaterials scienceImmunologyInternal medicineChemistrySARS-CoV-2HumansCOVID-19Reproducibility of ResultsEnzyme-Linked Immunosorbent AssayAntibodies, Viral

Sustainable Development Goals

SDG 0: Clean water and sanitation